3.17
前日終値:
$3.19
開ける:
$3.18
24時間の取引高:
63,140
Relative Volume:
1.26
時価総額:
$138.41M
収益:
$6.29M
当期純損益:
$-92.76M
株価収益率:
-1.2765
EPS:
-2.4834
ネットキャッシュフロー:
$-79.42M
1週間 パフォーマンス:
+3.59%
1か月 パフォーマンス:
-28.76%
6か月 パフォーマンス:
-29.40%
1年 パフォーマンス:
-72.02%
Nyxoah Sa Stock (NYXH) Company Profile
Compare NYXH vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
NYXH
Nyxoah Sa
|
3.17 | 139.28M | 6.29M | -92.76M | -79.42M | -2.4834 |
|
ISRG
Intuitive Surgical Inc
|
469.98 | 167.61B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
158.27 | 44.35B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.26 | 36.19B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
42.67 | 34.11B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
226.31 | 33.24B | 5.40B | 1.49B | 1.78B | 10.12 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-07-31 | 開始されました | H.C. Wainwright | Buy |
| 2023-07-19 | 開始されました | Robert W. Baird | Neutral |
| 2022-04-21 | 開始されました | Oppenheimer | Outperform |
| 2022-04-06 | 開始されました | Wolfe Research | Peer Perform |
| 2021-12-21 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-07-28 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Nyxoah Sa (NYXH) 最新ニュース
Breakout Zone: Is Nyxoah SA a speculative investment2026 Rallies & Entry Point Strategy Guides - baoquankhu1.vn
Cantor Fitzgerald Reiterates Overweight Rating for NYXH, Price T - GuruFocus
Cantor Fitzgerald reiterates Nyxoah stock rating on U.S. launch - Investing.com UK
Nyxoah's (NYXH) Overweight Rating Reaffirmed at Cantor Fitzgerald - MarketBeat
Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $10 - 富途牛牛
New Highs: Will Nyxoah SA benefit from rising consumer demandQuarterly Risk Review & Reliable Intraday Trade Plans - baoquankhu1.vn
Nyxoah SA (NYXH) reports Q4 loss, misses revenue estimates - MSN
Nyxoah Details Early U.S. Genio Launch, Reimbursement Update at Oppenheimer MedTech Conference 2026 - MarketBeat
Nyxoah Discloses Taub Group’s 10.14% Stake After Threshold Crossing - TipRanks
Nyxoah (ENXTBR:NYXH) Losses Of €90 Million Keep Bearish Cash Runway Concerns In Focus - simplywall.st
Publication relating to transparency notifications - GlobeNewswire
Stifel Nicolaus Issues Pessimistic Forecast for Nyxoah (NASDAQ:NYXH) Stock Price - MarketBeat
Nyxoah (NYXH) Q4 2025 Earnings Call Transcript - AOL.com
NYXH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Nyxoah SA (NYXH) Q4 2025 Earnings Call Highlights: U.S. Launch Success and Financial Challenges By GuruFocus - Investing.com Canada
Nyxoah (NASDAQ:NYXH) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Nyxoah Q4 2025 Earnings Call Transcript - MarketBeat
Nyxoah SA reports results for the quarter ended December 31Earnings Summary - TradingView
NYXH: FDA approval and U.S. launch fueled 122% revenue growth and strong Q4 momentum - TradingView
Nyxoah Q4 Earnings Call Highlights - MarketBeat
Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
NYXH: Transformative U.S. launch drove 122% revenue growth and strong Q4 momentum - TradingView
Nyxoah Leverages First Full U.S. Sales Quarter to Power Triple-Digit 2025 Revenue Growth - TipRanks
Nyxoah (NASDAQ: NYXH) doubles 2025 revenue as U.S. launch drives growth but losses deepen - Stock Titan
Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - 富途牛牛
Nyxoah SA (NYXH) Posts Fourth Quarter Loss, Falls Short of Revenue Expectations - Bitget
What is the long term forecast for Nyxoah SA stockWeekly Trade Summary & AI Driven Stock Movement Reports - baoquankhu1.vn
Earnings To Watch: Nyxoah SA (XBRU:NYXH) Reports Q4 2025 Result - GuruFocus
Nyxoah SA expected to post a loss of 53 cents a shareEarnings Preview - TradingView
Earnings Preview: Nyxoah SA to Report Financial Results on March 19 - 富途牛牛
Publication relating to transparency notification - GlobeNewswire
Nyxoah price target lowered to EUR 5 from EUR 7 at Baird - MSN
Nyxoah (NYXH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference - GlobeNewswire
Trading Recap: Will Nyxoah SA benefit from rising consumer demandShare Buyback & Target Return Focused Picks - baoquankhu1.vn
Will Nyxoah SA benefit from rising consumer demandJuly 2025 Gainers & AI Driven Stock Movement Reports - baoquankhu1.vn
Technical Analysis: Does Nyxoah SA have a competitive edgeJuly 2025 Final Week & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Aug Ideas: Can Nyxoah SA sustain its profitabilityPortfolio Growth Summary & Low Drawdown Investment Strategies - baoquankhu1.vn
Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026 - The Manila Times
Nyxoah SA (NASDAQ:NYXH) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Cantor Fitzgerald Upgrades Nyxoah (NASDAQ:NYXH) to "Strong-Buy" - MarketBeat
Nyxoah (NYXH) Expected to Announce Earnings on Thursday - MarketBeat
Nyxoah SA (NASDAQ:NYXH) Short Interest Down 17.8% in February - MarketBeat
Trading the Move, Not the Narrative: (NYXH) Edition - Stock Traders Daily
Nyxoah (NYXH) Stock Forecast & Price Target - Investing.com
Nyxoah SA (NYXH) Stock Analysis: Exploring a 149% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Information on the total number of voting rights and shares - GlobeNewswire
EV Market: Should value investors consider CNVSTrade Signal Summary & Stock Market Timing Techniques - baoquankhu1.vn
Macro Review: Can Nyxoah SA expand into new marketsJuly 2025 Update & High Accuracy Investment Signals - baoquankhu1.vn
How The Nyxoah (ENXTBR:NYXH) Story Is Shifting As Assumptions And Risks Are Reworked - Yahoo Finance
What’s Nyxoah SA’s historical returnQuarterly Growth Report & Technical Entry and Exit Tips - mfd.ru
Nyxoah Sa (NYXH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):